BFA
KBIO

BlackRock Fund Advisors’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

BlackRock Fund Advisors’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,396
Closed -$64K – 4007
2015
Q1 		$64K Buy
16,396
+8,641
+111% +$38.8K ﹤0.01% 3674
2014
Q4 		$107K Buy
7,755
+4,140
+115% +$59.1K ﹤0.01% 3613
2014
Q3 		$45K Sell
3,615
-263
-7% -$3.63K ﹤0.01% 3718
2014
Q2 		$71K Sell
3,878
-36,693
-90% -$628K ﹤0.01% 3657
2014
Q1 		$880K Buy
40,571
+1,124
+3% +$32.6K ﹤0.01% 3199
2013
Q4 		$1.4M Buy
39,447
+7,700
+24% +$258K ﹤0.01% 3173
2013
Q3 		$1.15M Buy
31,747
+3,702
+13% +$169K ﹤0.01% 3170
2013
Q2 		$1.27M Buy
+28,045
New +$1.27M ﹤0.01% 3139

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $46.9M AUM 7.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return